Does Permanent Pacemaker Status Confer Mortality Benefit in the Short Term Post TAVI

Does Permanent Pacemaker Status Confer Mortality Benefit in the Short Term Post TAVI

Pacemaker requirement in the immediate post procedure phase following TAVI is approximately 20% depending on device type and patient characteristics. There is a signal from recent studies suggesting increased risk of sudden cardiac / unexplained death in the first 30-60 days. This study aims to address whether there is a mortality advantage to having a pacemaker in the short term

Inclusion Criteria:

• All patients post TAVI

Exclusion Criteria:

• Nil